SCP
NNVC icon

Seizert Capital Partners’s NanoViricides NNVC Stock Holding History

Seizert Capital Partners’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-614
Closed -$15K – 232
2015
Q3 		$15K Buy
+614
New +$16.2K ﹤0.01% 196

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $138M AUM 7.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Seizert Capital Partners's NNVC Position: Q4 2015 in Review

Seizert Capital Partners sold out of NanoViricides (NNVC) in Q4 2015, closing a stake of 614 shares — an estimated $15K sold.

Seizert Capital Partners first reported a position in NNVC in Q3 2015 and held it in 1 quarter. The position peaked at $15K in Q3 2015. 41 funds tracked by Wall St. Rank hold NNVC as of Q4 2015.

  • Seizert Capital Partners reported no remaining NanoViricides position as of Q4 2015 after selling out during the quarter.
  • Seizert Capital Partners sold 614 NanoViricides shares in Q4 2015, an estimated $15K.
  • Seizert Capital Partners first reported a position in NanoViricides in Q3 2015 and held it in 1 quarter.
  • Seizert Capital Partners's NanoViricides position peaked at $15K in Q3 2015.
  • 41 funds tracked by Wall St. Rank held NanoViricides as of Q4 2015.

Based on Seizert Capital Partners's 13F filing for Q4 2015, filed 8 Feb 2016.